Trial of PI-88 With Dacarbazine in Patients With Metastatic Melanoma

NCT00130442 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

134

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma

Interventions

DRUG: PI-88 and dacarbazine
DRUG: dacarbazine or DTIC

Sponsor

Cellxpert Biotechnology Corp.

Collaborators

[object Object]